Oncology Institute (TOI) Competitors $3.94 -0.04 (-0.88%) As of 10:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. OMDA, AHCO, PNTG, CDNA, FTRE, FLGT, CSTL, INNV, PSNL, and AUNAShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Omada Health (OMDA), AdaptHealth (AHCO), The Pennant Group (PNTG), CareDx (CDNA), Fortrea (FTRE), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), InnovAge (INNV), Personalis (PSNL), and Auna (AUNA). These companies are all part of the "healthcare" industry. Oncology Institute vs. Its Competitors Omada Health AdaptHealth The Pennant Group CareDx Fortrea Fulgent Genetics Castle Biosciences InnovAge Personalis Auna Oncology Institute (NASDAQ:TOI) and Omada Health (NASDAQ:OMDA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Which has better earnings & valuation, TOI or OMDA? Omada Health has lower revenue, but higher earnings than Oncology Institute. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$424.38M0.87-$64.66M-$0.68-5.82Omada Health$209.83M6.63N/AN/AN/A Do insiders and institutionals have more ownership in TOI or OMDA? 36.9% of Oncology Institute shares are held by institutional investors. 8.5% of Oncology Institute shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to TOI or OMDA? In the previous week, Omada Health had 3 more articles in the media than Oncology Institute. MarketBeat recorded 4 mentions for Omada Health and 1 mentions for Oncology Institute. Oncology Institute's average media sentiment score of 1.36 beat Omada Health's score of -0.06 indicating that Oncology Institute is being referred to more favorably in the media. Company Overall Sentiment Oncology Institute Positive Omada Health Neutral Is TOI or OMDA more profitable? Omada Health has a net margin of 0.00% compared to Oncology Institute's net margin of -14.26%. Omada Health's return on equity of 0.00% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-14.26% -1,527.21% -34.25% Omada Health N/A N/A N/A Do analysts prefer TOI or OMDA? Oncology Institute currently has a consensus target price of $7.00, suggesting a potential upside of 76.99%. Omada Health has a consensus target price of $25.00, suggesting a potential upside of 3.52%. Given Oncology Institute's stronger consensus rating and higher possible upside, research analysts plainly believe Oncology Institute is more favorable than Omada Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75Omada Health 1 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.60 SummaryOncology Institute beats Omada Health on 7 of the 13 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$371.68M$8.20B$6.13B$10.61BDividend YieldN/A2.83%5.69%4.71%P/E Ratio-5.8575.1985.8627.54Price / Sales0.8733.00540.53202.58Price / CashN/A22.8037.9261.55Price / Book79.107.0012.986.78Net Income-$64.66M$247.60M$3.30B$275.79M7 Day Performance14.97%1.25%4.73%2.99%1 Month Performance22.45%0.90%9.96%9.50%1 Year Performance1,127.88%13.30%84.61%35.97% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.408 of 5 stars$3.94-0.9%$7.00+77.9%+1,168.4%$367.01M$424.38M-5.77660Positive NewsAnalyst ForecastOMDAOmada HealthN/A$22.32-2.0%$24.50+9.8%N/A$1.31B$209.83M0.00849News CoveragePositive NewsAnalyst ForecastAHCOAdaptHealth3.6338 of 5 stars$8.68-2.4%$13.40+54.4%-12.7%$1.20B$3.26B16.0710,500Analyst ForecastPNTGThe Pennant Group3.9568 of 5 stars$25.18-0.9%$34.40+36.6%-24.3%$877.88M$695.24M32.287,000Analyst ForecastCDNACareDx4.6298 of 5 stars$14.86-0.5%$25.50+71.6%-54.0%$794.68M$333.79M14.57740News CoverageAnalyst ForecastFTREFortrea3.0531 of 5 stars$8.40-3.2%$11.50+36.9%-45.7%$788.14M$2.70B-0.7415,500News CoverageAnalyst UpgradeFLGTFulgent Genetics3.1345 of 5 stars$22.30-1.3%$25.33+13.6%+11.2%$691.46M$303.22M-13.431,313Positive NewsAnalyst ForecastCSTLCastle Biosciences2.5999 of 5 stars$22.36-1.5%$37.00+65.5%-21.4%$658.78M$332.07M-63.88540Analyst ForecastINNVInnovAge0.5392 of 5 stars$4.90+2.1%$5.00+2.0%+7.4%$651.06M$853.70M-21.302,440Analyst ForecastPSNLPersonalis3.097 of 5 stars$6.35+5.1%$7.42+16.8%+66.6%$535.61M$84.61M-4.96400Analyst ForecastAUNAAuna4.0874 of 5 stars$6.66flat$10.70+60.7%-2.7%$492.93M$1.17B7.5714,842Positive News Related Companies and Tools Related Companies Omada Health Alternatives AdaptHealth Alternatives The Pennant Group Alternatives CareDx Alternatives Fortrea Alternatives Fulgent Genetics Alternatives Castle Biosciences Alternatives InnovAge Alternatives Personalis Alternatives Auna Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
